A guest editorial published on the Web site of a leading cardiology society suggests that although helpful for many patients, drug-eluting stents are used too often and increase the risk of thrombosis by 0.6%, which could account for an extra 2,160 patient deaths annually. The editorial said bare metal stents are safer; but others suggest that the clotting problem associated with drug-eluting stents stems from the use of the device in patients with complications such as diabetes and that if patients continue to take aspirin and Plavix as prescribed after getting the stent, the risks largely are avoidable.

Full Story:

Related Summaries